[NDRA] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[NDRA] ENDRA Life Sciences Inc.
Announcement Date
14-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 30.90%
YoY- -20.88%
Quarter Report
NDRA's Result
NDRA's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 0 0 0 0 0 6 0 -
PBT -2,943 -2,858 -2,269 -3,323 -2,749 -2,825 -742 25.80%
Tax 3 2,858,199,145 121 235 0 0 381 -55.38%
NP -2,946 -2,858,202,003 -2,269 -3,323 -2,749 -2,825 -742 25.82%
Tax Rate - - - - - - - -
Total Cost 2,946 2,858,202,003 2,269 3,323 2,749 2,831 742 25.82%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -45,761.31 0.00 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.93 -1,327,722.12 -1.20 -5.77 -7.41 -14.40 -3.80 -20.90%
EPS Diluted -0.93 -1,327,722.12 -1.20 -5.77 -7.41 -14.40 -3.80 -20.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.